Your browser doesn't support javascript.
loading
Comparing the outcomes of robotic assisted radical prostatectomy in black and white men: Experience of a high-volume center
Noël, Jonathan; Moschovas, Marcio Covas; Sandri, Marco; Jaber, Abdel Rahman; Rogers, Travis; Patel, Vipul.
  • Noël, Jonathan; AdventHealth Global Robotics Institute. Celebration. US
  • Moschovas, Marcio Covas; AdventHealth Global Robotics Institute. Celebration. US
  • Sandri, Marco; University of Brescia. Big and Open Data, Innovation Laboratory. Brescia. IT
  • Jaber, Abdel Rahman; AdventHealth Global Robotics Institute. Celebration. US
  • Rogers, Travis; AdventHealth Global Robotics Institute. Celebration. US
  • Patel, Vipul; AdventHealth Global Robotics Institute. Celebration. US
Int. braz. j. urol ; 49(1): 123-135, Jan.-Feb. 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1421714
ABSTRACT
ABSTRACT Background: Global cancer incidence ranks Prostate Cancer (CaP) as the second highest overall, with Africa and the Caribbean having the highest mortality. Previous literature suggests disparities in CaP outcomes according to ethnicity, specifically functional and oncological are suboptimal in black men. However, recent data shows black men achieve post radical prostatectomy (RP) outcomes equivalent to white men in a universally insured system. Our objective is to compare outcomes of patients who self-identified their ethnicity as black or white undergoing RP at our institution. Materials and methods: From 2008 to 2017, 396 black and 4929 white patients underwent primary robotic-assisted radical prostatectomy (RARP) with a minimum follow-up of 5 years. Exclusion criteria were concomitant surgery and cancer status not available. A propensity score (PS) match was performed with a 1:1, 1:2, and 1:3 ratio without replacement. Primary endpoints were potency, continence recovery, biochemical recurrence (BCR), positive surgical margins (PSM), and post-operative complications. Results: After PS 1:1 matching, 341 black vs. 341 white men with a median follow-up of approximately 8 years were analyzed. The overall potency and continence recovery at 12 months was 52% vs 58% (p=0.3) and 82% vs 89% (p=0.3), respectively. PSM rates was 13.4 % vs 14.4% (p = 0.75). Biochemical recurrence and persistence PSA was 13.8% vs 14.1% and 4.4% vs 3.2% respectively (p=0.75). Clavien-Dindo complications (p=0.4) and 30-day readmission rates (p=0.5) were similar. Conclusion: In our study, comparing two ethnic groups with similar preoperative characteristics and full access to screening and treatment showed compatible RARP results. We could not demonstrate outcomes superiority in one group over the other. However, this data adds to the growing body of evidence that the racial disparity gap in prostate cancer outcomes can be narrowed if patients have appropriate access to prostate cancer management. It also could be used in counseling surgeons and patients on the surgical intervention and prognosis of prostate cancer in patients with full access to gold-standard screening and treatment.


Full text: Available Index: LILACS (Americas) Type of study: Prognostic study Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2023 Type: Article Affiliation country: Italy / United States Institution/Affiliation country: AdventHealth Global Robotics Institute/US / University of Brescia/IT

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Type of study: Prognostic study Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2023 Type: Article Affiliation country: Italy / United States Institution/Affiliation country: AdventHealth Global Robotics Institute/US / University of Brescia/IT